153 related articles for article (PubMed ID: 38394504)
21. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
Fung MHM; Lang BHH
Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
[TBL] [Abstract][Full Text] [Related]
22. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
Azizi F; Abdi H; Amouzegar A
BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
[TBL] [Abstract][Full Text] [Related]
23. Long-term thionamide antithyroid treatment of Graves' disease.
Azizi F; Abdi H; Amouzegar A; Habibi Moeini AS
Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101631. PubMed ID: 35440398
[TBL] [Abstract][Full Text] [Related]
24. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
25. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
26. Radioiodine therapy versus antithyroid medications for Graves' disease.
Ma C; Xie J; Wang H; Li J; Chen S
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Follow-up of Graves Orbitopathy After Treatment With Short- or Long-Term Methimazole or Radioactive Iodine.
Azizi F; Abdi H; Mehran L; Perros P; Masoumi S; Amouzegar A
Endocr Pract; 2023 Apr; 29(4):240-246. PubMed ID: 36649782
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of methimazole before the administration of radioactive iodine in the management of Graves' disease: a systematic review and meta-analysis.
Bolakale-Rufai IK; Abioro I; Ngene SO; Woldeamanuel Y
Sao Paulo Med J; 2023; 141(5):e2022225. PubMed ID: 36629663
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves' Disease and Methimazole-Induced Liver Injury.
Purnamasari D; Wildan A; Kurniawan J; Mulansari NA; Karim B; Danil Yulian E
Int J Endocrinol Metab; 2023 Jul; 21(3):e136608. PubMed ID: 38028251
[TBL] [Abstract][Full Text] [Related]
30. A rare case of methimazole-induced cholestatic jaundice in an elderly man of Asian ethnicity with hyperthyroidism: A case report.
Ji H; Yue F; Song J; Zhou X
Medicine (Baltimore); 2017 Dec; 96(49):e9093. PubMed ID: 29245333
[TBL] [Abstract][Full Text] [Related]
31. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
Saadat N; Azizi F; Abdi H; Amouzegar A
J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
[TBL] [Abstract][Full Text] [Related]
32. Methimazole-induced cholestatic hepatitis: two cases report and literature review.
Zou H; Jin L; Wang LR; Braddock M; Cai WW; Zheng MH
Oncotarget; 2016 Jan; 7(4):5088-91. PubMed ID: 26498145
[TBL] [Abstract][Full Text] [Related]
33. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
34. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
35. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
36. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
[TBL] [Abstract][Full Text] [Related]
38. Graves' disease overlapping with chronic hepatitis B and methimazole-induced liver injury and autoimmune hepatitis: a case report.
Zheng M; Cui S; Zhang W; Brigstock DR; Gao R
BMC Gastroenterol; 2022 Feb; 22(1):59. PubMed ID: 35144533
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
40. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
